GSK plc 13F Portfolio

EntityCategoryQoQ AUM ChangeAUM (13F)# of HoldingsPerformance RankEquities Trend
GP
GSK plc
Institutional Filer 25.01%$599.2M13

Current Portfolio Holdings

Showing all 13 reported positions by value

#StockCompany NameSectorShares HeldMarket Value% of Portfolio
1CRSPCRISPR Therapeutics AGHealthcare3.2M$153.2M25.57%
2WVEWave Life Sciences Ltd.Healthcare18.2M$132.3M22.08%
3BNTXBioNTech SEHealthcare890K$79.1M13.20%
4VIRVir Biotechnology, Inc.Healthcare8.6M$76.6M12.79%
5IDYAIDEAYA Biosciences, Inc.Healthcare1.3M$44.4M7.41%
6LYELLyell Immunopharma, Inc.Healthcare1.5M$30.3M5.06%
7CYTKCytokinetics, IncorporatedHealthcare340K$22.4M3.74%
8SPROSpero Therapeutics, Inc.Healthcare9.2M$21.5M3.59%
9FULCFulcrum Therapeutics, Inc.Healthcare1.8M$13.7M2.29%
10CVRXCVRx, Inc.Healthcare1.0M$9.5M1.59%
11BCYCBicycle Therapeutics plcHealthcare1.5M$7.1M1.18%
12NKTXNkarta, Inc.Healthcare3.2M$6.6M1.11%
13RGNXREGENXBIO Inc.Healthcare271K$2.3M0.38%
Showing 1 to 13 of 13 holdings
GSK plc 13F Portfolio Holdings & Trades (Q1 2026) | VCP Scanner